The evolving CRISPR technology

References

[1] Abudayyeh OO, Gootenberg JS, Essletzbichler P, Han S, Joung J, Belanto JJ, Verdine V, Cox DBT, Kellner MJ, Regev A (2017) RNA targeting with CRISPR-Cas13. Nature 550:280–284

[2] Barrangou R, Doudna JA (2016) Applications of CRISPR technologies in research and beyond. Nat Biotechnol 34:933–941

[3] Chen BH, Gilbert LA, Cimini BA, Schnitzbauer J, Zhang W, Li GW, Park J, Blackburn EH, Weissman JS, Qi LS (2013) Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155:1479–1491

[4] Chen JS, Ma EB, Harrington LB, Da Costa M, Tian XR, Palefsky JM, Doudna JA (2018) CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science 360:436–439

[5] Cong L, Ran FA, Cox D, Lin SL, Barretto R, Habib N, Hsu PD, Wu XB, Jiang WY, Marraffini LA (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339:819–823

[6] Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR (2017) Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage. Nature 551:464–471

[7] Gilbert LA, Larson MH, Morsut L, Liu ZR, Brar GA, Torres SE, Stern-Ginossar N, Brandman O, Whitehead EH, Doudna JA (2013) CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154:442–451

[8] Gootenberg JS, Abudayyeh OO, Kellner MJ, Joung J, Collins JJ, Zhang F (2018) Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science 360:439–444

[9] Halperin SO, Tou CJ, Wong EB, Modavi C, Schaffer DV, Dueber JE (2018) CRISPR-guided DNA polymerases enable diversification of all nucleotides in a tunable window. Nature 560:248–252

[10] Hess GT, Fresard L, Han K, Lee CH, Li A, Cimprich KA, Montgomery SB, Bassik MC (2016) Directed evolution using dCas9-targeted somatic hypermutation in mammalian cells. Nat Methods 13:1036–1042

[11] Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li YQ, Fine EJ, Wu XB, Shalem O (2013) DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31:827–832

[12] Hu JH, Miller SM, Geurts MH, Tang WX, Chen LW, Sun N, Zeina CM, Gao X, Rees HA, Lin Z (2018) Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature 556:57–63

[13] Jiang J, Yan M, Li D, Li J (2018) Genome tagging project: tag every protein in mice through ‘artificial spermatids’. Natl Sci Rev 6:394–396

[14] Kim YB, Komor AC, Levy JM, Packer MS, Zhao KT, Liu DR (2017) Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nat Biotechnol 35:371–376

[15] Koblan LW, Doman JL, Wilson C, Levy JM, Tay T, Newby GA, Maianti JP, Raguram A, Liu DR (2018) Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat Biotechnol 36:843–846

[16] Li Q, Li YJ, Yang SM, Huang S, Yan M, Ding YF, Tang W, Lou XW, Yin Q, Sun ZF (2018) CRISPR-Cas9-mediated base-editing screening in mice identifies DND1 amino acids that are critical for primordial germ cell development. Nat Cell Biol 20:1315–1325

[17] Liu XS, Wu H, Ji X, Stelzer Y, Wu XB, Czauderna S, Shu J, Dadon D, Young RA, Jaenisch R (2016) Editing DNA methylation in the mammalian genome. Cell 167:233–247

[18] Ma YQ, Zhang JY, Yin WJ, Zhang ZC, Song Y, Chang X (2016) Targeted AID-mediated mutagenesis (TAM) enables efficient genomic diversification in mammalian cells. Nat Methods 13:1029–1035

[19] Maeder ML, Linder SJ, Cascio VM, Fu YF, Ho QH, Joung JK (2013) CRISPR RNA-guided activation of endogenous human genes. Nat Methods 10:977–979

[20] McKenna A, Findlay GM, Gagnon JA, Horwitz MS, Schier AF, Shendure J (2016) Whole-organism lineage tracing by combinatorial and cumulative genome editing. Science 353:aaf7907

[21] Men K, Duan XM, He ZY, Yang Y, Yao SH, Wei YQ (2017) CRISPR/Cas9-mediated correction of human genetic disease. Sci China Life Sci 60:447–457

[22] Nishimasu H, Shi X, Ishiguro S, Gao LY, Hirano S, Okazaki S, Noda T, Abudayyeh OO, Gootenberg JS, Mori H (2018) Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science 361:1259–1262

[23] Ren B, Yan F, Kuang YJ, Li N, Zhang DW, Lin HH, Zhou HB (2017a) A CRISPR/Cas9 toolkit for efficient targeted base editing to induce genetic variations in rice. Sci China Life Sci 60:516–519

[24] Ren XJ, Holsteens K, Li HY, Sun J, Zhang YF, Liu LP, Liu QF, Ni JQ (2017b) Genome editing in Drosophila melanogaster: from basic genome engineering to the multipurpose CRISPR-Cas9 system. Sci China Life Sci 60:476–489

[25] Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, Doench JG (2014) Genomescale CRISPR-Cas9 knockout screening in human cells. Science 343:84–87

[26] Shen L, Hua YF, Fu YP, Li J, Liu Q, Jiao XZ, Xin GW, Wang JJ, Wang XC, Yan CJ (2017) Rapid generation of genetic diversity by multiplex CRISPR/Cas9 genome editing in rice. Sci China Life Sci 60:506–515

[27] Tanenbaum ME, Gilbert LA, Qi LS, Weissman JS, Vale RD (2014) A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell 159:635–646

[28] Thakore PI, Black JB, Hilton IB, Gersbach CA (2016) Editing the epigenome: technologies for programmable transcription and epigenetic modulation. Nat Methods 13:127–137

[29] Wang FY, Qi LS (2016) Applications of CRISPR genome engineering in cell biology. Trends Cell Biol 26:875–888

[30] Wu YX, Liang D, Wang YH, Bai MZ, Tang W, Bao SM, Yan ZQ, Li DS, Li JS (2013) Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell 13:659–662

[31] Wu YX, Zhou H, Fan XY, Zhang Y, Zhang M, Wang YH, Xie ZF, Bai MZ, Yin Q, Liang D (2015) Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells. Cell Res 25:67–79

[32] Xue CX, Zhang HW, Lin QP, Fan R, Gao CX (2018) Manipulating mRNA splicing by base editing in plants. Sci China Life Sci 61:1293–1300

[33] Yang H, Shi LY, Wang BA, Liang D, Zhong CQ, Liu W, Nie YZ, Liu J, Zhao J, Gao X (2012) Generation of genetically modified mice by oocyte injection of androgenetic haploid embryonic stem cells. Cell 149:605–617

[34] Zhang XH, Wang LR, Liu MY, Li DL (2017) CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy. Sci China Life Sci 60:468–475

[35] Zhong CQ, Yin Q, Xie ZF, Bai MZ, Dong R, Tang W, Xing YH, Zhang HL, Yang SM, Chen LL (2015) CRISPR-Cas9-mediated genetic screening in mice with haploid embryonic stem cells carrying a guide RNA library. Cell Stem Cell 17:221–232

[36] Zuo E, Sun Y, Wei W, Yuan T, Ying W, Sun H, Yuan L, Steinmetz LM, Li Y, Yang H (2019) Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos. Science 364:289–292

RIGHTS & PERMISSIONS

2019 The Author(s)